Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clin Neurophysiol Pract ; 4: 20-26, 2019.
Article in English | MEDLINE | ID: mdl-30847430

ABSTRACT

OBJECTIVES: To assess interrater variability and prognostic value of simple EEG features based on the recent American Clinical Neurophysiology Society (ACNS) classification in post cardiac arrest comatose patients. METHODS: All patients admitted for a resuscitated cardiac arrest in a university hospital were prospectively included in the study. EEG interpretation was made by 3 independent neurophysiologists (2 senior and 1 junior) blind to the outcome. Kappa score and prognostic performances were estimated for each EEG pattern and discrepancies were analyzed. RESULTS: 122 cardiac arrest patients were admitted of whom 48 went through a full neurologic evaluation. Eighty-one percent had an unfavorable outcome. Burst suppression, paroxystic seizure activity, and non-reactive EEG were strongly associated with an unfavorable evolution. Kappa score between the senior neurophysiologists was excellent or substantial while it was only fair or slight between the junior and senior neurophysiologists. Reactivity, discontinuity and electrographic seizure were patterns particularly subject to discrepancy. CONCLUSIONS: Bedside EEG is an excellent tool for predicting outcome of post-anoxic coma through simple EEG features. However, the interrater variability emphasizes the need to be well trained for the standardized methods of evaluating EEG parameters. SIGNIFICANCE: A second look at complex patterns seems mandatory. The development of automated tools could help to improve the reliability of EEG interpretation.

2.
Clin Immunol ; 177: 18-28, 2017 04.
Article in English | MEDLINE | ID: mdl-26598010

ABSTRACT

Immune thrombocytopenic purpura (ITP) is a disease characterized by antibody-mediated platelet destruction. The T- and B-cell subsets have been extensively studied in primary ITP, but the NK cell compartment has been less thoroughly explored. We investigated the NK cell receptor repertoire and the functionality of NK cells in the peripheral blood and spleen in patients with primary ITP. An immunophenotypic analysis of peripheral blood lymphocytes from patients revealed that the numbers of CD19+ B lymphocytes, CD4+ and CD8+ T lymphocytes and CD3-CD56+ NK cells were within the normal range. No major alteration to the expression of distinct inhibitory or activating NK cell receptors was observed. The functionality of NK cells, as evaluated by their ability to degranulate in conditions of natural cytotoxicity or antibody-dependent cell cytotoxicity (ADCC), was preserved in these patients. By contrast, these stimuli induced lower levels of IFNγ production by the NK cells of ITP patients than by those of healthy controls. We then compared the splenic NK cell functions of ITP patients with those of cadaveric heart-beating donors (CHBD) as controls. The splenic NK cells of ITP patients tended to be less efficient in natural cytotoxicity conditions and more efficient in ADCC conditions than control splenic NK cells. Finally, we found that infusions of intravenous immunoglobulin led to the inhibition of NK cell activation through the modulation of the interface between target cells and NK cells.


Subject(s)
Killer Cells, Natural/immunology , Purpura, Thrombocytopenic, Idiopathic/immunology , Adult , Aged , Aged, 80 and over , Animals , Cell Line, Tumor , Cells, Cultured , Female , Humans , Immunoglobulins, Intravenous/pharmacology , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/pharmacology , Immunologic Factors/therapeutic use , Interferon-gamma/blood , Interferon-gamma/immunology , K562 Cells , Killer Cells, Natural/drug effects , Leukocytes, Mononuclear , Male , Mice , Middle Aged , Purpura, Thrombocytopenic, Idiopathic/blood , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Spleen/cytology , Spleen/immunology , Young Adult
3.
Clin Exp Rheumatol ; 33(2 Suppl 89): S-116-21, 2015.
Article in English | MEDLINE | ID: mdl-26016761

ABSTRACT

OBJECTIVES: To describe the clinical-biological phenotype of ANCA-associated vasculitides (AAV) according to tobacco consumption. METHODS: We conducted a descriptive study to describe that phenotype at diagnosis according to tobacco use. AAV patients entered in the French Vasculitis Study Group database with data on smoking habits were analysed. The clinical-biological phenotypes at diagnosis were compared according to current tobacco use (current smokers) or not (including previous and never smokers). RESULTS: AAV diagnoses were: granulomatosis with polyangiitis (GPA) for 583 (50%), eosinophilic granulomatosis with polyangiitis (EGPA) for 326 (28%) and microscopic polyangiitis (MPA) for 256 (22%). Among them, 973 patients (84%) never smoked, 116 (10%) were previous smokers and only 76 (6%) were current smokers. Current smokers were younger age (p=0.01), male gender (p=0.004), less frequently EGPA (p=0.017) and MPA (p=0.036), and had less frequent kidney involvement (p=0.10). Among GPA patients, current smokers, compared to non-current smokers, were younger age (p=0.02), male gender (p=0.08), more frequent skin involvement (p=0.03) and less frequent ENT involvement (p=0.06). Among EGPA patients, current smokers, compared to non-current smokers, were also younger (p=0.028) and had less frequent constitutional symptoms (p=0.02), arthralgias (p=0.04), renal involvement (p=0.025) and MPO-ANCA (p=0.02). Finally, analysis of MPA patients was impossible because only 6 (2%) were current smokers. CONCLUSIONS: These results suggest that tobacco use could differentially affect GPA and EGPA clinical-biological phenotypes, and support the role of environmental exposures in AAV development and its phenotype.


Subject(s)
Churg-Strauss Syndrome/epidemiology , Granulomatosis with Polyangiitis/epidemiology , Microscopic Polyangiitis/epidemiology , Smoking/epidemiology , Adult , Age Distribution , Aged , Antibodies, Antineutrophil Cytoplasmic/immunology , Arthralgia/etiology , Churg-Strauss Syndrome/complications , Churg-Strauss Syndrome/immunology , Female , Fever/etiology , France/epidemiology , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/immunology , Humans , Male , Microscopic Polyangiitis/complications , Microscopic Polyangiitis/immunology , Middle Aged , Myeloblastin/immunology , Peripheral Nervous System Diseases/etiology , Peroxidase/immunology , Phenotype , Retrospective Studies , Severity of Illness Index , Sex Distribution , Skin Diseases, Vascular/etiology , Weight Loss
4.
Rev Med Interne ; 31(6): 440-4, 2010 Jun.
Article in French | MEDLINE | ID: mdl-20398975

ABSTRACT

INTRODUCTION: Posterior reversible encephalopathy syndrome is a clinico-radiological entity characterized by neurologic symptoms in association with usually reversible bilateral posterior hemispheric oedema on neuroimaging. Many pathological conditions and treatments have been associated with this syndrome. CASE REPORT: We report a 19-year-old woman, followed-up for hypocomplementemic urticarial vasculitis, who presented with a posterior reversible encephalopathy syndrome induced by the intake of an over-the-counter cold remedy containing pseudoephedrine. Clinical manifestations and radiological abnormalities resolved after anti-hypertensive therapy and withdrawal of sympathomimetic drug. CONCLUSION: The diagnosis of posterior reversible encephalopathy syndrome should be considered in patients with compatible clinical and radiological presentation because of its potential reversibility with an appropriate management. Intake of drugs, including over-the-counter cough and cold drugs, should be looked for in the history as well as autoimmune disorders.


Subject(s)
Bronchodilator Agents/adverse effects , Hypertensive Encephalopathy/chemically induced , Pseudoephedrine/adverse effects , Adult , Antihypertensive Agents/therapeutic use , Bronchodilator Agents/administration & dosage , Common Cold/drug therapy , Cough/drug therapy , Drug Eruptions/etiology , Female , Humans , Hypertensive Encephalopathy/diagnosis , Hypertensive Encephalopathy/drug therapy , Prognosis , Pseudoephedrine/administration & dosage , Syndrome , Treatment Outcome , Urticaria/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...